COIOSDeep risk insights through multi-disciplinary research across the globe
white and brown concrete building near green trees during daytime
Item refines Preprint · not peer-reviewed Added

Blood p-tau217 tracked Alzheimer's-type brain shrinkage but not ordinary ageing

Among 818 adults with no cognitive symptoms in the Baltimore Longitudinal Study of Aging, p-tau217 was the only blood marker associated with later shrinkage of the medial temporal lobe.

Five blood markers, among them p-tau217, were measured in 818 adults who had no cognitive symptoms, then set against 2,293 later MRI scans. Over follow-up 104 developed mild cognitive impairment or dementia, 74 of them from Alzheimer's disease. p-tau217 was associated with those Alzheimer's cases, and with shrinkage in the brain areas typical of Alzheimer's, but not with the shrinkage of ordinary ageing.

Why it is interesting: Separates shrinkage specific to Alzheimer's from the shrinkage of ordinary ageing, in people still free of symptoms.

Source
medRxiv, 17 September 2026
Paper
Association of plasma biomarkers with longitudinal change in age- and Alzheimer’s disease-related brain atrophy patterns
Authors
Bilgel M, Shah I, Cooper J, An Y, Walker KA, Ho SG et al.
DOI
10.64898/2026.09.11.26362869
Type
Preprint
Design
Prospective cohort, Baltimore Longitudinal Study of Aging: 818 cognitively unimpaired adults, 2,293 serial MRIs, 104 conversions to MCI/dementia
Verdict
Refines prior evidence
Driver
Dementia

Other drivers in Health today